MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Pulse Biosciences Total Shareholders Equity 2011-2026 | PLSE
Annual Total Shareholders Equity Pulse Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80.7 M | 115 M | 44.4 M | -2.25 M | 35.7 M | 22.9 M | 30.7 M | 66.3 M | 46 M | 25.3 M | 13.7 M | 16.1 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 115 M | -2.25 M | 41.2 M |
Quarterly Total Shareholders Equity Pulse Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.7 M | 104 M | 118 M | 115 M | 79.1 M | 27 M | 36.3 M | 44.4 M | 52.1 M | 60.5 M | -10.7 M | -2.25 M | 6.19 M | 23.4 M | 20.8 M | 44.4 M | 47.4 M | 59.8 M | 20.4 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 30.7 M | 30.7 M | 30.7 M | 30.7 M | 66.3 M | 66.3 M | 66.3 M | 66.3 M | 46 M | 46 M | 46 M | 46 M | 25.3 M | 25.3 M | 25.3 M | 25.3 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 118 M | -10.7 M | 40.3 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M |  USA |
 |
Ekso Bionics Holdings
EKSO
|
9.03 M | $ 11.16 | -0.49 % | $ 27.1 M | USA |
 |
Alcon
ALC
|
18.8 B | $ 73.13 | -3.01 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
2.12 B | $ 116.04 | -4.11 % | $ 2.86 B | USA |
 |
The Cooper Companies
COO
|
8.24 B | $ 62.28 | -1.28 % | $ 12.4 B | USA |
 |
Microbot Medical
MBOT
|
77.6 M | $ 2.05 | -2.6 % | $ 93.9 M |  Israel |
 |
Milestone Scientific
MLSS
|
2.81 M | $ 0.3 | -8.8 % | $ 24.6 M | USA |
 |
iRhythm Technologies
IRTC
|
153 M | $ 121.29 | -3.31 % | $ 3.88 B | USA |
 |
Haemonetics Corporation
HAE
|
821 M | $ 59.07 | -1.14 % | $ 2.97 B | USA |
 |
electroCore
ECOR
|
-1.71 M | $ 6.25 | 1.63 % | $ 53 K | USA |
 |
Repro Med Systems
KRMD
|
17 M | $ 4.03 | -1.23 % | $ 186 M | USA |
 |
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
17.8 B | $ 450.66 | -3.43 % | $ 161 B | USA |
 |
STAAR Surgical Company
STAA
|
344 M | $ 25.96 | -2.77 % | $ 1.29 B | USA |
 |
Glaukos Corporation
GKOS
|
462 M | $ 115.82 | -3.23 % | $ 5.61 B | USA |
 |
STERIS plc
STE
|
6.6 B | $ 211.72 | -3.82 % | $ 20.9 B | USA |
 |
Teleflex Incorporated
TFX
|
3.12 B | $ 135.79 | 0.21 % | $ 6.06 B | USA |
 |
Masimo Corporation
MASI
|
1.05 B | $ 178.45 | -0.03 % | $ 9.51 B | USA |
 |
InfuSystem Holdings
INFU
|
48 M | $ 9.83 | -3.44 % | $ 203 M | USA |
 |
Merit Medical Systems
MMSI
|
1.58 B | $ 64.63 | -3.16 % | $ 3.82 B | USA |
 |
Utah Medical Products
UTMD
|
119 M | $ 66.05 | -0.85 % | $ 214 M | USA |
 |
West Pharmaceutical Services
WST
|
3.18 B | $ 294.0 | 0.68 % | $ 21.3 B | USA |
 |
Envista Holdings Corporation
NVST
|
3.11 B | $ 25.98 | -1.96 % | $ 4.36 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 11.49 | -2.5 % | $ 2.29 B | USA |
 |
Retractable Technologies
RVP
|
74.4 M | $ 0.62 | -3.12 % | $ 18.6 M | USA |
 |
Pro-Dex
PDEX
|
36.6 M | $ 50.62 | -1.73 % | $ 166 M | USA |
 |
LeMaitre Vascular
LMAT
|
394 M | $ 109.67 | -2.43 % | $ 2.48 B | USA |
 |
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
349 M | $ 20.33 | -2.73 % | $ 937 M | USA |
 |
Stereotaxis
STXS
|
13.5 M | $ 1.78 | -4.56 % | $ 162 M | USA |
 |
Baxter International
BAX
|
6.13 B | $ 16.99 | -5.35 % | $ 8.72 B | USA |
 |
ResMed
RMD
|
3.36 B | $ 212.65 | -1.99 % | $ 31.1 B | USA |
 |
AtriCure
ATRC
|
492 M | $ 27.56 | -3.23 % | $ 1.32 B | USA |
 |
Harvard Bioscience
HBIO
|
13.7 M | $ 6.25 | -3.1 % | $ 277 M | USA |
 |
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
183 M | $ 10.59 | -3.55 % | $ 433 M | USA |
 |
Becton, Dickinson and Company
BDX
|
25.4 B | $ 145.34 | -2.78 % | $ 41.8 B | USA |
 |
Nephros
NEPH
|
8.36 M | $ 3.27 | -1.51 % | $ 34 M | USA |
 |
OraSure Technologies
OSUR
|
341 M | $ 2.95 | -2.16 % | $ 217 M | USA |
 |
Repligen Corporation
RGEN
|
1.96 B | $ 112.82 | -3.93 % | $ 6.29 M | USA |